Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in.
Supremes tweaking Twiqbal?
Securities fraud ruling could impact pleading standards and more
The U.S. Supreme Court's recent ruling that non-scientific reports can be used by investors to support a securities fraud claim against a drug manufacturer could give a boost to plaintiffs in a host of other areas of litigation, including drug liability and mass tort claims.